Diabetes, Overweight and Obesity: From Molecular Mechanisms to Therapies Strategies

A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Medicine".

Deadline for manuscript submissions: 31 December 2024 | Viewed by 49

Special Issue Editors


E-Mail Website
Guest Editor
Interdisciplinary Metabolic Medicine Trials Unit, Division of Endocrinology and Diabetology, Medical University of Graz, 8010 Graz, Austria
Interests: diabetology; exercise; glucose metabolism
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The aim of this Special Issue is to transfer existing knowledge of molecular mechanisms, obtained via clinical trials, to potential use in the routine care of people with diabetes, overweight, and obesity. In recent years, several novel glucose-lowering drugs have emerged; we do not yet fully understand their mechanisms of action and future roles in clinical treatment regimens. A close interplay between basic, translational, and clinical research is necessary to improve treatment options for people with diabetes, overweight, and obesity. In this context, we invite the submission of manuscripts concerning diabetes, overweight, and obesity. Topics may include but are not limited to

  • Beta cell function and treatment options for enhancing it;
  • The interplay of beta and alpha cells;
  • Treatment options for modulating peripheral and liver insulin sensitivity;
  • Glucose transporter (GLUT) modulation;
  • Novel mechanisms of action of glucose-lowering drugs;
  • Molecular mechanisms related to lifestyle interventions;
  • The pathophysiologic role of the gut microbiome and interventions for modulating the microbiome in metabolic diseases;
  • The role of inflammation in the treatment of diabetes and associated complications;
  • Novel molecules for the treatment of diabetes, overweight, and obesity;
  • The relationship between liver metabolism and diabetes.

Dr. Othmar Moser
Dr. Harald Sourij
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • diabetes mellitus
  • overweight
  • obesity
  • molecular mechanisms
  • microbiome
  • liver metabolism
  • advanced therapy

Related Special Issue

Published Papers

This special issue is now open for submission.
Back to TopTop